Ignite Creation Date:
2024-07-17 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467084
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-14
Brief Title:
Open-Label Safety PK and Efficacy Trial of Sebetralstat KVD900 in Pediatric Patients Ages 2-11 with HAE Type I or II
Sponsor:
KalVista Pharmaceuticals Ltd
Organization:
KalVista Pharmaceuticals Ltd
Study Overview
Official Title:
Open-Label Safety Pharmacokinetic and Efficacy Trial of Sebetralstat KVD900 in Pediatric Patients Ages 2-11 with Hereditary Angioedema Type I or II
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KONFIDENT-KID
Brief Summary:
KVD900-303 is an open-label multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None